Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - STOCK-BASED COMPENSATION
Stock-based Compensation ALNY - Alnylam Pharmaceuticals, Inc.
272 M
LAST VALUE
8.61%
2 YEAR CAGR
9.25%
5 YEAR CAGR
23.46%
10 YEAR CAGR